Viewing Study NCT06527885



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06527885
Status: COMPLETED
Last Update Posted: None
First Post: 2024-07-26

Brief Title: Lurasidone Non-Interventional Study in Schizophrenia Patients
Sponsor: None
Organization: None

Study Overview

Official Title: Treatment Satisfaction and Effectiveness of Lurasidone on Quality of Life and Functioning in Adult Patients With Schizophrenia Treated in the Real World Italian Clinical Practice
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study is a multicentric national non-interventional prospective single arm study

The main goal of this study is to gather information about the effects in a real-life setting of lurasidone treatment on patients reported outcomes in terms of patients treatment satisfaction Quality of Life and functioning changes after 6 weeks from lurasidone treatment initiation in schizophrenia patients naïve to lurasidone
Detailed Description: Important aim of the study is to investigate aspects related to effectiveness safety and tolerability at 3 months lurasidone treatment in a routine practice in Italian clinical settings

Only patients with primary diagnosis of schizophrenia who are prescribed lurasidone was evaluated for inclusion in the study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None